Literature DB >> 121073

Biochemical and immunological studies on the P400 protein, a protein characteristic of the Purkinje cell from mouse and rat cerebellum.

K Mikoshiba, M Huchet, J P Changeux.   

Abstract

The P400 protein is a glycoprotein of high apparent molecular weight which is abundant in isolated cerebellar Purkinje cells. On SDS polyacrylamide gels, the P400 protein reacts with 125I plant lectins such as 125I Con A. This reaction is used to increase the level of detection of the protein. The P400 protein is purified by successive extraction of synaptosomal and microsomal membranes with 2% Triton X-100 and 25% Na-cholate and preparative gel electrophoresis in SDS. The specific content of P400 protein decreases in the cerebella from homozygous nervous and Purkinje cell degeneration mutant mice, where the total number of Purkinje cells is markedly reduced, and increases in those of the reeler and weaver mice where a deficit of the granule cells exists. In the cerebellum from the homozygous staggerer mouse, a small amount of P400 protein persists. During postnatal development the specific content of P400 protein per net weight does not change up to the 12th day after birth then increases up to the 25th day when it reaches the adult level. Antisera have been raised against the purified P400 protein. They give precipitation lines by the immunodiffusion reaction of Ouchterlony against a preparation of P400 protein submitted to mild proteolytic attack. Indirect immunofluorescence performed on slices of rat cerebellum with purified anti-P400 immunoglobulin G, absorbed or not on rat cerebrum membranes, reveals that both the soma and the dendritic arborization of the Purkinje cells are labelled. The neurons from the deep cerebellar nuclei are not stained.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121073     DOI: 10.1159/000112489

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  9 in total

1.  The subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in a tissue-specific and developmentally specific manner.

Authors:  T Nakagawa; H Okano; T Furuichi; J Aruga; K Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 2.  ORAI Calcium Channels.

Authors:  Mohamed Trebak; James W Putney
Journal:  Physiology (Bethesda)       Date:  2017-07

3.  Development and expression of cytoplasmic antigens in Purkinje cells recognized by monoclonal antibodies. Studies in neurologically mutant mice.

Authors:  A Weber; M Schachner
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

4.  Two proteins associated with cerebellar hypoplasia in jaundiced Gunn rats.

Authors:  S Aono; H Sato; R Semba; S Kashiwamata
Journal:  Neurochem Res       Date:  1983-06       Impact factor: 3.996

5.  Staggerer-specific protein SP47: a unique species among age- and genotype-dependent cerebellar proteins.

Authors:  U A Heinlein; C Ruppert; W Wille
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

6.  A cerebellar Purkinje cell marker P400 protein is an inositol 1,4,5-trisphosphate (InsP3) receptor protein. Purification and characterization of InsP3 receptor complex.

Authors:  N Maeda; M Niinobe; K Mikoshiba
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

Review 7.  Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations.

Authors:  Songbai Zhang; Nicolas Fritz; Cristian Ibarra; Per Uhlén
Journal:  Neurochem Res       Date:  2011-04-11       Impact factor: 3.996

8.  Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway.

Authors:  Melanie Vanessa Halbach; Suzana Gispert; Tanja Stehning; Ewa Damrath; Michael Walter; Georg Auburger
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

Review 9.  Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update.

Authors:  Jessica Gambardella; Angela Lombardi; Marco Bruno Morelli; John Ferrara; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.